Syneos Health
Generated by Meeveem AI
"Integrated biopharmaceutical solutions accelerating novel therapies from clinical trials to market"
About Syneos Health
Syneos Health combines clinical research, medical affairs and commercial expertise to help biopharmaceutical companies develop and launch therapies. Its capabilities span Phase I to Phase IV and commercialisation. The company says it has helped develop or commercialise 93% of novel FDA-approved drugs over the last five years, including support for 96% of FDA-approved novel oncology drugs.
Formed in 2017 through the merger of INC Research and inVentiv Health, Syneos Health has more than 26,000 employees, including over 460 MDs and 700 PhDs. Headquartered in Morrisville, NC, it operates in more than 60 countries. Its UK offices include Farnborough and London, with work spanning clinical development, medical affairs and commercial services.
Learning and progression
Syneos Health describes development through training for new and existing colleagues, leadership resources under its Everyone Is a Leader framework and a technology-enabled mentoring programme. A structured performance process combines goal setting, regular check-ins, coaching and year-end reviews. Its global Employee Assistance Programme provides confidential counselling, coaching and everyday support.
23205
Team Members
2017
Founded
Contract Research
Sector
Hybrid
Work Environment